Gene discovery presents osteoporosis therapy target

The discovery of a gene that regulates bone growth may provide a therapeutic target to prevent osteoporosis, scientists say.

Researchers studying the effects of aging on bone deterioration in mice found the gene Maf regulates the creation of cells responsible for bone formation or degradation.

The team, led by Keizo Nishikawa of Tokyo Medical and Dental University in Japan, believe the discovery may provide a molecular basis for preventing or treating age-related osteoporosis.

Bone marrow contains mesenchymal cells, capable of forming a variety of cell types. These include osteoblasts, which promote bone growth, and adipocytes, which lay down marrow fat.

As the body ages, mesenchymal cells are more likely to differentiate into adipocytes, which inhibit bone formation and lay down marrow fat, therefore causing osteoporosis.

This effect is also seen in diabetic patients taking thiazolidinediones, suggesting that treatment to alleviate this process could have benefits for osteoporosis related to age and drug use.

Researchers screened the mouse genome for mRNAs expressed in bone formation, which identified Maf.

In healthy mice, Maf regulates the creation of osteoblasts and adipocytes by cooperating with transcription factor Runx2. It also downregulates Pparg, a gene causes aggregation of marrow fat.

Mice bred to lack functioning Maf genes suffered impaired bone formation and accelerated age-related osteoporosis.

Researchers found that at least some of the age-related decline in Maf expression was due to oxidative stress, known to play a role in disrupting biological systems in aging.

The authors concluded: ‘The modulation of Maf expression appears to hold considerable promise as what we believe to be a novel antiaging therapeutic target in the skeletal system.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs raise alarm over low uptake of COVID-19 vaccine in BAME patients

GPs raise alarm over low uptake of COVID-19 vaccine in BAME patients

GPs across England have raised concerns over low uptake of COVID-19 vaccination among...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

COVID-19 vaccination programme widens to over-70s and clinically vulnerable

COVID-19 vaccination programme widens to over-70s and clinically vulnerable

People aged over 70 and those who are clinically extremely vulnerable will be offered...

Hoarse voice - red flag symptoms

Hoarse voice - red flag symptoms

Dr Suneeta Kochhar provides an overview into the red flag symptoms to look for in...

Epistaxis - red flag symptoms

Epistaxis - red flag symptoms

Dr Suneeta Kochhar provides an overview of red flag symptoms to look for in a patient...

Former Brexit secretary backs vitamin D supplements to beat COVID-19

Former Brexit secretary backs vitamin D supplements to beat COVID-19

The NHS should provide 10 times the current daily recommended amount of vitamin D...